Vendor entity record · non-Growth scope

Next Edge Peptides reference record

This record connects Peptide Index’s published review, score context, available public-source context, and dated listing observations. It does not verify products, current terms, checkout outcomes, or vendor performance.

Published score

8.9/10

Rank 5 · derived from the published scoring method.

Code-listing status

PERKS10

A periodic code listing. Availability is not guaranteed.

Documentation context

Testing-documentation expansion announced

This label is a scoring-input summary, not a claim that every document is current or complete.

Connected Peptide Index resources

Full vendor review

Score breakdown, limitations, and Next Edge Peptides review context.

Open resource

Promo code & discount code information

Periodic code-listing information with availability limits.

Open resource

Documentation & scoring context

Published category inputs and stated source limitations.

Open resource

Dated price observations

1 dated public listing observation currently recorded.

Open resource

Platform update history

See methodology and editorial updates affecting the platform.

Open resource

Vendor directory

Compare the published record against other covered non-Growth vendors.

Open resource

Source-linked snapshots

Dated public listing observations

No basket or trend output

These are dated public listing snapshots, not checkout prices, product availability, tax, shipping, quality, or value claims. They are not treated as comparable enough for an average or trend.

GLP-3 (Reta) 10mg
August 23, 2026 · public listing snapshot
$108.00Source

Public-source and change context

Historical merchant-source information was observed on August 22, 2026. This is separate from the current code-verification record. Next Edge Peptides shipping policy is linked as source context; Published policy language and future plans may change. This summary does not confirm delivery outcomes, product availability, prices, code availability, service performance, or that planned testing documentation is currently available.

Price trends and score-history charts are deliberately withheld until repeat dated observations or prior score records exist. This avoids manufacturing change over time.